Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bluestar Adisseo Company (600299.SS)
Beijing, CN
Bluestar Adisseo Company operates as a global leader in the development, production, and distribution of specialized feed additives for animal nutrition. The company's diverse product portfolio includes Rhodimet, a range of methionine-based solutions for monogastric animals, offered in both solid (Rhodimet NP99) and liquid (Rhodimet AT88) forms. Additionally, it provides advanced nutritional formulas, such as Smartamine and MetaSmart, which are engineered to ensure optimal amino acid balance in the diets of lactating dairy cows and other ruminants. Its Microvit range offers a comprehensive selection of vitamins essential for the feed industry. Adisseo also produces a diverse array of enzyme preparations under the Rovabio brand, formulated to enhance the digestibility of plant-based raw materials for various animal species, including poultry and swine. Another significant offering is Selisseo 2% Se, an organic selenium source based on seleno-hydroxy-methionine, designed for integration into animal feed. The firm supplies AdiSodium, a chloride-free sodium alternative that supports dietary electrolyte balance in monogastric feeds and delivers an assimilable form of sulfur to ruminant diets. Furthermore, Alterion is provided to improve animal gut health and overall performance by fostering a balanced intestinal micro-ecosystem. Complementing its product portfolio, the company provides several specialized services. PNE utilizes Near-Infrared (NIR) technology to accurately predict the nutritional quality of feed raw materials. DiM offers dedicated assistance and application support for its Rhodimet AT88 product. Lastly, E-lab is an online portal facilitating analytical requests and simplifying sample identification for customers prior to shipment to Adisseo's laboratories. Founded in 1939 and headquartered in Beijing, China, Bluestar Adisseo Company functions as a subsidiary of China National Bluestar (Group) Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.25% | -0.08% | -16.73% | +25.15% | +30.04% | +40.91% | +27.16% | +54.15% | +2.51% | -2.09% | +58.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+10.9% ★ Q1'26: +2.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-4.4% Q1'26: -41.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+8.1% Q1'26: +4.7% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+9.4% ★ Q1'26: +9.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.8% ★ Q1'26: +7.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.1% Q1'26: +11.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.59× ★ Q1'26: 1.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.40B
est: 9.81B (+5.9%)
|
11.42B
est: 11.24B (+1.5%)
|
11.14B
est: 11.56B (-3.7%)
|
11.91B
est: 12.31B (-3.2%)
|
12.87B
est: 13.20B (-2.5%)
|
14.53B
est: 14.92B (-2.6%)
|
13.18B
est: 14.12B (-6.6%)
|
15.53B
est: 15.11B (+2.8%)
|
17.23B
est: 16.95B (+1.7%)
|
22.12B
21.52B – 22.72B
+30.5% YoY
|
21.82B
20.83B – 22.81B
-1.4% YoY
|
21.70B
21.70B – 21.70B
-0.5% YoY
|
| EBITDA |
3.04B
est: 2.11B (+44.1%)
|
2.68B
est: 2.42B (+10.6%)
|
2.47B
est: 2.49B (-0.8%)
|
3.26B
est: 2.65B (+23.0%)
|
3.25B
est: 2.84B (+14.5%)
|
2.90B
est: 3.21B (-9.8%)
|
1.90B
est: 2.79B (-31.8%)
|
3.20B
est: 2.99B (+7.1%)
|
3.20B
est: 3.35B (-4.5%)
|
4.37B
4.25B – 4.49B
+30.5% YoY
|
4.31B
4.12B – 4.51B
-1.4% YoY
|
4.29B
4.29B – 4.29B
-0.5% YoY
|
| EBIT |
2.23B
est: 1.18B (+88.6%)
|
1.73B
est: 1.36B (+27.6%)
|
1.49B
est: 1.39B (+7.0%)
|
2.14B
est: 1.48B (+44.2%)
|
2.14B
est: 1.59B (+34.1%)
|
1.64B
est: 1.80B (-9.0%)
|
307.51M
est: 1.46B (-79.0%)
|
1.89B
est: 1.56B (+20.5%)
|
1.62B
est: 1.76B (-7.4%)
|
2.29B
2.23B – 2.35B
+30.5% YoY
|
2.26B
2.16B – 2.36B
-1.4% YoY
|
2.25B
2.25B – 2.25B
-0.5% YoY
|
| Net Income |
1.32B
est: 1.42B (-6.9%)
|
926.13M
est: 1.19B (-22.4%)
|
992.38M
est: 1.03B (-4.0%)
|
1.35B
est: 1.45B (-7.0%)
|
1.47B
est: 1.63B (-9.6%)
|
1.25B
est: 1.47B (-15.3%)
|
52.17M
est: 626.36M (-91.7%)
|
1.20B
est: 1.34B (-9.9%)
|
1.15B
est: 1.29B (-10.2%)
|
2.93B
2.79B – 3.07B
+127.9% YoY
|
2.92B
2.17B – 2.93B
-0.2% YoY
|
1.95B
1.77B – 2.13B
-33.2% YoY
|
| SGA |
1.48B
est: 1.43B (+3.1%)
|
1.86B
est: 1.64B (+13.2%)
|
1.89B
est: 1.69B (+12.2%)
|
1.94B
est: 1.79B (+8.1%)
|
1.83B
est: 1.92B (-4.7%)
|
1.86B
est: 2.18B (-14.7%)
|
1.99B
est: 1.54B (+29.4%)
|
2.25B
est: 1.65B (+36.8%)
|
-371.74M
est: 1.85B (-120.1%)
|
2.41B
2.34B – 2.47B
+30.5% YoY
|
2.38B
2.27B – 2.48B
-1.4% YoY
|
2.36B
2.36B – 2.36B
-0.5% YoY
|
| EPS |
0.49
est: 0.53 (-7.5%)
|
0.35
est: 0.45 (-21.3%)
|
0.37
est: 0.39 (-4.0%)
|
0.50
est: 0.54 (-7.0%)
|
0.55
est: 0.61 (-9.4%)
|
0.46
est: 0.54 (-13.1%)
|
0.02
est: 0.23 (-91.4%)
|
0.45
est: 0.48 (-5.6%)
|
0.43
est: 0.48 (-10.2%)
|
1.09
1.04 – 1.14
+127.9% YoY
|
0.95
0.81 – 1.09
-13.1% YoY
|
0.73
0.66 – 0.79
-23.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Agribusiness UCITS ETF ISAG.L | 0.05% | 240.5K | 0.55% |
| 2 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.03% | 10.9K | 0.65% |
| 3 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 97.5K | 0.19% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 23.6K | 0.44% |
| 5 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 38.2K | 0.46% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 150.3K | 0.29% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 17.4K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 39.2K | 0.26% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.94M | 0.06% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 96.7K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Frank Chmitelin | Deputy General Manager | — | male |
| Frederic Jacquin | Chief Operating Officer & Deputy GM | — | male |
| Jean-François Rous | Deputy General Manager | — | male |
| Virginie Cayatte | Chief Financial Officer & Accounting Supervisor | — | female |
| Yun Cai | Secretary to the Board | — | female |
| Zhigang Hao | Chief Executive Officer & Chairman | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600299.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
